Literature DB >> 1785944

Ultrastructural basis for antigen mapping using sodium chloride-separated skin.

S Kárpáti1, W Stolz, M Meurer, O Braun-Falco, T Krieg.   

Abstract

In many cases of autoimmune blistering skin diseases indirect immunofluorescence with serum of patients on 1 M NaCl-separated skin represents a rapid diagnostic tool before the use of more complicated immunoelectron microscopy. The present study demonstrates that in skin samples from five adults, separated using 1 M NaCl, 0.15 M NaCl and 0.01 M phosphate buffered saline (PBS), the split formed within the lamina lucida at an identical ultrastructural level. The sub-basal dense plate (SDP) with a wreath of anchoring filaments remained on the epidermal side of the split adjacent to the hemidesmosomal part of the plasma membrane of basal keratinocytes. The base of the split blister was constituted from the lamina densa, with a remote possibility of some anchoring filaments attached. We demonstrate that antigens on the roof of the NaCl- or PBS-split blister may be associated, beside intracellular hemidesmosomal structures, with the SDP and basement membrane components between the SDP and the basal keratinocytes as well as with anchoring filaments attached to the SDP. The observations reported here allow a more precise mapping of antigen determinants in blistering skin diseases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1785944     DOI: 10.1007/bf00371928

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  12 in total

1.  The presence of intra-lamina lucida blister formation in epidermolysis bullosa acquisita: possible role of leukocytes.

Authors:  J D Fine; S Tyring; W R Gammon
Journal:  J Invest Dermatol       Date:  1989-01       Impact factor: 8.551

2.  Detection and partial characterization of a midlamina lucida-hemidesmosome-associated antigen (19-DEJ-1) present within human skin.

Authors:  J D Fine; Y Horiguchi; J Jester; J R Couchman
Journal:  J Invest Dermatol       Date:  1989-06       Impact factor: 8.551

3.  Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita.

Authors:  W R Gammon; C Kowalewski; T P Chorzelski; V Kumar; R A Briggaman; E H Beutner
Journal:  J Am Acad Dermatol       Date:  1990-04       Impact factor: 11.527

4.  Epidermolysis bullosa acquisita. Incidence in patients with basement membrane zone antibodies.

Authors:  X J Zhu; Y Niimi; J C Bystryn
Journal:  Arch Dermatol       Date:  1990-02

5.  Localization of the alpha 3 (V) chain of type V collagen in human skin.

Authors:  D T Woodley; V J Scheidt; M J Reese; A S Paller; T O Manning; T Yoshiike; R A Briggaman
Journal:  J Invest Dermatol       Date:  1987-03       Impact factor: 8.551

6.  Localization of bullous pemphigoid antibody--an indirect immunofluorescence study of 228 cases using a split-skin technique.

Authors:  R A Logan; B Bhogal; A K Das; P M McKee; M M Black
Journal:  Br J Dermatol       Date:  1987-10       Impact factor: 9.302

7.  Ultrastructural morphometry of normal human dermal-epidermal junction. The influence of age, sex, and body region on laminar and nonlaminar components.

Authors:  M J Tidman; R A Eady
Journal:  J Invest Dermatol       Date:  1984-12       Impact factor: 8.551

8.  Isolation and immunologic identification of basement membrane zone antigens from human skin.

Authors:  L J Scaletta; J C Occhino; D K MacCallum; J H Lillie
Journal:  Lab Invest       Date:  1978-07       Impact factor: 5.662

9.  Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin.

Authors:  W R Gammon; R A Briggaman; A O Inman; L L Queen; C E Wheeler
Journal:  J Invest Dermatol       Date:  1984-02       Impact factor: 8.551

10.  Expression of a pemphigoid gestationis-related antigen by human placenta.

Authors:  S E Kelly; B S Bhogal; F Wojnarowska; M M Black
Journal:  Br J Dermatol       Date:  1988-05       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.